News + PR
Most Recent
Bushu Pharma awarded at Asia-Pacific Biologics CMO Excellence Awards 2023
Bushu Pharma received 2 awards at the Asia-Pacific Biologics CMO Excellence Awards (APBCEA) 2023 hosted by IMAPAC in Singapore.
Asia Pacific Biologics CMO Excellence Awards 2023 seeks to give recognition to the leading CMO/CDMO’s in the Asia Pacific regions.
Bushu Pharma is honored to have been recognized and awarded in the categories for “Best Biologics CMO Award Scale-Up” and “Best Biologics CMO in Japan”.
Bushu Pharmaceuticals will participate at Interphex Week Tokyo
News Bushu Pharmaceuticals will participate at Interphex Week Tokyo Bushu Pharmaceuticals will exhibit at the Interphex Week Tokyo at Tokyo Big Sight from July 5th to 7th. Date: July 5th (Wednesday) to July 7th (Friday) Time: 10:00-17:00 Venue: Tokyo Big Sight East Exhibition Hall 1 Hall Contract Services Zone Booth number: 10-48 Closest Train Station: Yurikamome Line -Tokyo Big Sight Station or Rinkai Line – International Exhibition Hall Station If you are interested in having a meeting with us, please email us in advance at contact@bushu-pharma.com We look forward to meeting you! News + PR Interested in Partnering with us? CONTACT US
Meet Bushu Pharma at DCAT Week 2023 in New York
Bushu Pharma will attend DCAT Week 2023, from 20-23 March, at the InterContinental in New York Barclay. We’re looking forward to reconnecting with old colleagues and meeting new ones.
Notice of Shareholder Change
KKR, a leading global investment firm, and Bushu Pharmaceuticals Ltd. (“Bushu Pharma” or the “Company”) today announced the signing of definitive agreements under which KKR will acquire all shares in Bushu Pharma from BPEA EQT. Following the transaction’s completion, KKR aims to accelerate Bushu Pharma’s growth and further position the Company as a leading contract development and manufacturing organization (“CDMO”) for the pharmaceuticals market in Japan and worldwide.
Bushu Pharmaceutical is shortlisted in the “Supply Chain, Logistics & Distribution” category of the CPHI Pharma Awards
We are humbled with the great news received from CPHI today.
Bushu Pharmaceutical is shortlisted in the “Supply Chain, Logistics & Distribution” category of the CPHI Pharma award for our unique supply chain management service, Gateway to Asia.
Visit us at Messe Frankfurt Hall 9 Booth 90F83 to discuss the business possibilities including Gateway to Asia.
Bushu Pharmaceuticals will participate in CPHI Worldwide 2022 in Frankfurt for the first time in three years.
Bushu Pharma is thrilled to be participating at this year’s CPHI Worldwide 2022 in Frankfurt for the first time in three years.
Talk to us about our Gateway to Asia supply chain services that will allow you to expand into Japan and Asia.
With Japan and Asia such an attractive market, this will be an ideal opportunity for your business expansion.
We look forward to seeing you!
Notice Concerning the Opening of Aizu Factory in Fukushima Prefecture
Bushu Pharmaceuticals Ltd. (Kawagoe City, Saitama Prefecture) is pleased to announce the completion of the transfer of FUKUSHIMA Factory’s business from Sanwa Kagaku Kenkyusho Co., Ltd.
With the completion of the business transfer, the name of the factory will be changed to Aizu Factory, and it will help further growth as an important production base for Bushu Pharmaceuticals, which provides high quality pharmaceutical products as a contract manufacturing factory.
Bushu Pharmaceuticals will participate in LogiPharma for the first time.
LogiPharma has been bringing together the top minds in life sciences and healthcare supply chain, logistics, distribution, planning, IT, quality and sourcing to share emerging best practices.
At this event, Bushu Pharma will have an exhibition booth and shall also give a presentation at 3.25pm on the first day of the event during the “Spot Innovation” program to introduce its unique supply chain management services,” Gateway to Asia” and contract manufacturing services. (Presenter: Susan Lynch-Smith, Head of Business Development & Marketing, N.A. and Europe)
Frost & Sullivan recognizes Bushu Pharmaceuticals as the Market Leader
Bushu Pharmaceuticals has been recognized by Frost & Sullivan, an independent research and consulting firm, as a market leader in the pharmaceutical contract manufacturing industry. As a result, the company received the “2022 Japan Pharmaceutical Contract Manufacturing and Supply Chain Market Leadership Customer Value Award”.
Bushu Pharmaceuticals will participate in the AMERICAN PHARMA OUTSOURCING SUMMIT for the first time.
The summit is designed to provide pharmaceutical executives with current trends, strategic insights and best practices in manufacturing, outsourcing, capacity management, quality assurance, quality control, regulatory compliance, operational excellence, supply chain and logistics.
At the Summit, Bushu Pharma will have an exhibition booth to introduce the unique supply chain management services, Gateway to Asia, and contract manufacturing services.
News + PR
Interested in Partnering with us?
